Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020 Mullen expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 followed by its own EV SUV in 2022 Deloitte expects annual EV sales to rise from 2.5mn in 2020 to 31.1mn in 2030, implying […]

AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and chronic pancreatitis – an established global market of more than $2 billion The company is currently pursuing parallel monotherapy and combination therapy trials, which are anticipated to produce topline data in Q1 […]

Scientific research suggests some mushrooms can provide mental benefits, anti-tumor effects, improved immune function, anti-viral properties and detoxification “Psychedelic” varieties currently being studied for depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease, addiction Pure Extracts is expanding into functional mushroom market; Company is currently licensed by Health Canada to buy, sell, produce cannabis products Mushrooms have […]

180 Life Sciences is a clinical-stage biotechnology company developing anti-tumor necrosis factor (“TNF”) therapies to treat a variety of inflammatory conditions. Phase 2b/3 clinical trials on fibrosis and inflammation-causing TNF irregularity are currently underway with first results expected in 2021 The company is to be acquired by a SPAC (NASDAQ: KBLM) and will be listed […]

Gage Cannabis is one of the leading vertically integrated operators in the cannabis industry Its current focus is the Michigan market, which is valued at an estimated $3 billion and recorded $109 million in cannabis sales in August 2020 The company currently has five dispensaries across Michigan, with the potential to have 90% of the […]

CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working to build on promising results from a 2006 Phase I trial, which provided 44 percent of its limited patient pool with clinically significant improvement in disease stability and one patient with a durable complete response […]

Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s divisions, has reiterated his optimism on company’s operations going forward CEO also revealed that company’s revenue trends have stabilized and are now on upward trend with cash burn beginning to decline Company also revealed its […]

KAVL recently acquired patent, announced creation of wholly owned subsidiary to develop smoking cessation products. Company plans to create products that satisfy smokers but are free from nicotine’s addictive traits. CEO says company is excited to help “all nicotine users lead healthier and higher-quality lives.” The Centers for Disease Control and Prevention report that smoking […]

SGTM awarded contract for tree services in Lake County, Florida through subsidiary Central Florida Arborcare SGTM subsidiary Mulch Manufacturing recently awarded two additional packaging contracts Subsidiary ArborPro of Mississippi Inc. awarded contract for Hurricane Laura recovery efforts Q2 results include $12.3 million revenue and $3.4 million gross profit Sustainable Green Team (OTC: SGTM), a leading […]

Pure Extract Technologies has been awarded Standard Processing License by Health Canada The license will enable the Company to produce, sell cannabis & hemp products to other Licenced Producers in its purpose-built facility located near Whistler, Canada Canada’s ability to export worldwide coupled with Company’s EU-GMP compliant facility makes Pure Extracts a natural partner for […]